Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences

Rhea-AI Summary

Intra-Cellular Therapies, a biopharmaceutical firm focused on CNS disorders, announced that CEO Sharon Mates will present at two investor conferences. The first presentation will be at the Bank of America 2021 Healthcare Conference on May 11 at 5:00 PM ET, followed by the 2021 RBC Capital Markets Global Healthcare Conference on May 18 at 9:10 AM ET. Archived webcasts will be available on their website. The company utilizes Nobel prize-winning research to develop innovative therapies for psychiatric and neurological conditions.

NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at two upcoming investor conferences:

Bank of America 2021 Healthcare Conference
Tuesday, May 11 at 5:00 pm ET

2021 RBC Capital Markets Global Healthcare Conference
Tuesday, May 18 at 9:10 am ET

The live and archived webcasts can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D. 
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

Source: Intra-Cellular Therapies Inc.

FAQ

When is Intra-Cellular Therapies presenting at the Bank of America 2021 Healthcare Conference?

Intra-Cellular Therapies will present at the Bank of America 2021 Healthcare Conference on May 11 at 5:00 PM ET.

What is the date and time for Intra-Cellular Therapies' presentation at the RBC Capital Markets Global Healthcare Conference?

The presentation at the RBC Capital Markets Global Healthcare Conference is scheduled for May 18 at 9:10 AM ET.

Where can I access the webcasts for Intra-Cellular Therapies' investor presentations?

The webcasts can be accessed under 'Events & Presentations' in the Investor Relations section of Intra-Cellular Therapies' website.

What type of company is Intra-Cellular Therapies?

Intra-Cellular Therapies is a biopharmaceutical company focused on developing treatments for central nervous system disorders.

Who is the CEO of Intra-Cellular Therapies?

Sharon Mates, Ph.D., is the CEO and Chairman of Intra-Cellular Therapies.